Engineered aminotransaminase catalyzes chiral amine production via site-directed mutagenesis.
A PTH1 ligand-bound nucleic acid complex directs antisense oligonucleotides to target organs via receptor-mediated uptake.
Enzymatic synthesis using metabolically engineered microorganisms overcomes low yields and complex protection steps in chemical globoside production.
Engineered Eubacterium rectale reverse transcriptase achieves enhanced processivity to resolve low read length accuracy in complex RNA sequencing applications.
Polyribonucleotides encoding ornithine transcarbamylase replace liver transplantation by restoring enzyme activity.
Mutant DNA polymerases with specific amino acid substitutions increase reverse transcriptase efficiency for primer extension methods.
Squalene-hopene cyclase replaces harsh chemical oxidation, reducing energy consumption and eliminating polluting waste during sclareolide production.
Inverted terminal repeats direct transgene integration into the host genome, eliminating harmful episomal expression bursts.
Heterologous acylating acetaldehyde dehydrogenase converts acetaldehyde to acetyl-CoA without ATP expenditure.
Engineered immune cells express heterologous polynucleotides to promote thanotransmission, overcoming limited tumor reduction in current immunotherapies.
An A138T plant EPSPS mutant provides glyphosate resistance without microbial transgenes, resolving public acceptance issues in crop engineering.
Targeted amino acid mutations in Pol6 polymerase decrease template dissociation, resolving nanopore sequencing instability at high salt concentrations.
Segmented variable regions optimize binding affinity for therapeutic efficacy.
Heterologous expression of octaketide synthase produces carminic acid, eliminating insect protein allergens and supply fluctuations.